Found Animals is providing up to $50 million in multiple, multi-year international research grants through the Michelson Grants in Reproductive Biology for promising proposals in pursuit of a single dose, lifetime non-surgical sterilization product or technology for use in male and female dogs and cats that also ablates sex steroids or their action. Although grant proposals may be funded to study a nonsurgical sterilant in a single target species (cats or dogs), a single gender, or that does not ablate sex steroids, strong preference is given to proposals that could meet all of the Michelson Prize criteria. The Foundation seeks proposals for up to $250,000 USD per year for up to 3 years of funding.
The foundation encourages scientists from any and all fields to compete for the Michelson Grants, including but not limited to researchers in disciplines such as biology, biotechnology, cell biology, endocrinology, gene silencing, immunology, materials science, nanotechnology, neuroscience, pharmacology, reproductive biology, theriogenology, and more. The Michelson Grants is open to any entity from any country.
The goal of the Michelson Prize & Grants in Reproductive Biology is the funding of research toward development of a dog and cat sterilant that Found Animals Foundation will guide through regulatory approval, manufacture, marketing and distribution to ensure that the sterilant has a maximum possible impact in addressing the serious problem of cat and dog overpopulation. Accordingly, upon approval of Michelson Grant proposals, and as a condition of funding, applicant institutions are required to enter into grant agreements with the Foundation. More information about grant agreements is available here.
All animal research performed for the Michelson Grants in Reproductive Biology must conform to Found Animals' standards for humane treatment of animal subjects, as outlined in the Policy for Animals Involved in Research.